StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note published ...

In the assessment of 12-month price targets, analysts unveil insights for RadNet, presenting an average target of $73.4, a ...

Tempero Bio, Inc., a clinical-stage biopharmaceutical company developing transformative treatments for substance use disorders, today announced the closing of a $70 million Series B financing. The ...

According to Telix Pharmaceuticals, the product has a longer shelf-life (up to 6 hours) and an extended distribution radius compared with other gallium-based products.

Cibc World Markets Corp purchased a new position in RadNet, Inc. (NASDAQ:RDNT – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and ...